Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-04 08:35 am Purchase |
2023-12-31 | 13G | Cyngn Inc. CYN |
SABBY MANAGEMENT LLC | 355 11.000% |
355 (New Position) |
Filing History |
| 2024-01-04 08:15 am Purchase |
2023-12-31 | 13G | Phunware, Inc. PHUN |
SABBY MANAGEMENT LLC | 200,132 11.000% |
200,132 (New Position) |
Filing History |
| 2024-01-04 08:00 am Purchase |
2023-12-31 | 13G | iBio, Inc. IBIO |
SABBY MANAGEMENT LLC | 200,303 11.000% |
200,303 (New Position) |
Filing History |
| 2024-01-03 6:56 pm Purchase |
2023-12-31 | 13G | TransGlobe Energy Corporation TGA |
SABBY MANAGEMENT LLC | 5,338,587 11.000% |
5,338,587 (New Position) |
Filing History |
| 2024-01-03 5:43 pm Purchase |
2023-12-31 | 13G | InMed Pharmaceuticals Inc. INM |
SABBY MANAGEMENT LLC | 1,312 11.000% |
1,312 (New Position) |
Filing History |
| 2024-01-03 4:59 pm Purchase |
2023-12-31 | 13G | Lipella Pharmaceuticals Inc. LIPO |
SABBY MANAGEMENT LLC | 72,477 11.000% |
72,477 (New Position) |
Filing History |
| 2024-01-03 4:44 pm Purchase |
2023-12-31 | 13G | Bluejay Diagnostics, Inc. BJDX |
SABBY MANAGEMENT LLC | 444 11.000% |
322 (+264.83%) |
Filing History |
| 2024-01-03 4:23 pm Purchase |
2023-12-31 | 13G | Tonix Pharmaceuticals Holding Corp. TNXP |
SABBY MANAGEMENT LLC | 1,627 11.000% |
1,627 (New Position) |
Filing History |
| 2024-01-03 3:59 pm Purchase |
2023-12-31 | 13G | Fangdd Network Group Ltd. DUO |
SABBY MANAGEMENT LLC | 107 11.000% |
107 (New Position) |
Filing History |
| 2024-01-03 1:54 pm Purchase |
2023-12-31 | 13G | GlucoTrack, Inc. GCTK |
SABBY MANAGEMENT LLC | 20,871 11.000% |
20,871 (New Position) |
Filing History |
| 2024-01-03 1:30 pm Purchase |
2023-12-31 | 13G | Recon Technology, Ltd. RCON |
SABBY MANAGEMENT LLC | 191,797 11.000% |
109,460 (+132.94%) |
Filing History |
| 2024-01-03 12:26 pm Purchase |
2023-12-31 | 13G | Arcadia Biosciences, Inc. RKDA |
SABBY MANAGEMENT LLC | 97,305 11.000% |
91,348 (+1533.54%) |
Filing History |
| 2024-01-03 09:26 am Purchase |
2023-12-31 | 13G | Mobiquity Technologies, Inc. MOBQ |
SABBY MANAGEMENT LLC | 144,867 11.000% |
144,867 (New Position) |
Filing History |
| 2024-01-03 08:36 am Purchase |
2023-12-31 | 13G | Revelation Biosciences, Inc. REVB |
SABBY MANAGEMENT LLC | 840 11.000% |
840 (New Position) |
Filing History |
| 2024-01-03 08:18 am Sale |
2023-12-31 | 13G | MMEX Resources Corporation MMEX |
SABBY MANAGEMENT LLC | 844,654,010 11.000% |
-7,610,341,086 (-90.01%) |
Filing History |
| 2024-01-03 08:14 am Purchase |
2023-12-31 | 13G | MMEX Resources Corporation MMEX |
SABBY MANAGEMENT LLC | 8,454,995,096 11.000% |
8,454,995,096 (New Position) |
Filing History |
| 2024-01-02 4:54 pm Sale |
2023-12-31 | 13G | BiondVax Pharmaceuticals Ltd. BVXV |
SABBY MANAGEMENT LLC | 220,663 11.000% |
-7,666 (-3.36%) |
Filing History |
| 2024-01-02 4:26 pm Sale |
2023-12-31 | 13G | RedHill Biopharma Ltd. RDHL |
SABBY MANAGEMENT LLC | 0 0.000% |
-12,065 (Position Closed) |
Filing History |
| 2024-01-02 4:13 pm Sale |
2023-12-31 | 13G | Huadi International Group Co., Ltd. HUDI |
SABBY MANAGEMENT LLC | 0 0.000% |
-1,422,494 (Position Closed) |
Filing History |
| 2024-01-02 4:05 pm Sale |
2023-12-31 | 13G | Kiromic BioPharma, Inc. KRBP |
SABBY MANAGEMENT LLC | 0 0.000% |
-60,762 (Position Closed) |
Filing History |